Sparfosic Acid
CAS No. 51321-79-0
Sparfosic Acid ( —— )
产品货号. M34033 CAS No. 51321-79-0
Sparfosic acid 是 DNA 抗代谢剂和天门冬氨酸氨甲酰转移酶 (aspartate transcarbamoyl transferase) 的有效抑制剂。Sparfosic acid 具有抗肿瘤活性。天冬氨酸氨甲酰转移酶催化第二步 de novo 嘧啶生物合成。Sparfosic acid 协同增强 5-氟尿嘧啶 (5-FU) 和干扰素-α (IFN) 对人结肠癌细胞系的细胞毒性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥2946 | 有现货 |
|
| 5MG | ¥4643 | 有现货 |
|
| 10MG | ¥6646 | 有现货 |
|
| 25MG | ¥9853 | 有现货 |
|
| 50MG | ¥12747 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sparfosic Acid
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Sparfosic acid 是 DNA 抗代谢剂和天门冬氨酸氨甲酰转移酶 (aspartate transcarbamoyl transferase) 的有效抑制剂。Sparfosic acid 具有抗肿瘤活性。天冬氨酸氨甲酰转移酶催化第二步 de novo 嘧啶生物合成。Sparfosic acid 协同增强 5-氟尿嘧啶 (5-FU) 和干扰素-α (IFN) 对人结肠癌细胞系的细胞毒性。
-
产品描述Sparfosic acid, a DNA antimetabolite agent, is a potent inhibitor of aspartate transcarbamoyl transferase, the enzyme catalyzing the second step of de novo pyrimidine biosynthesis. Sparfosic acid synergistically enhances the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines.
-
体外实验Sparfosic acid (N-(Phosphonacetyl)-L-aspartate, PALA) causes apoptosis in the resistant Br1 cells.Sparfosic acid (300 μM) shows progressive accumulation of cells in S phase and activation of an apoptotic pathway leading to cell death.:Cell Viability Assay Cell Line:Br-l and L-2 cell lines established from metastasis in nude mouse injected with the human tumor cell line MDA-MB-435 Concentration:300 μM Incubation Time:12, 24 and 48 hours Result:Cells were predominantly in S phase in both the cell lines, although slightly higher proportion of cells in S phase were noted in L-2 than Brl-3prl cells.Western Blot Analysis Cell Line:Br-l and L-2 cell lines Concentration:300 μM Incubation Time:4, 10 and 24 hours Result:There was moderate difference in the level of phosphorylated Rb proteins seen in the two cell types.Marked increase in the amount of cyclin A protein was detected in the L-2 cells undergoing apoptosis with the highest level detected at 10 h post-drug treatment.In contrast, there was no increase in the level of cyclin A seen in the Brl-3prl cells.Cyclin E protein was found elevated in the L-2 cells and Brl-3prl cells compared to their respective controls.
-
体内实验Sparfosic acid (490 mg/kg; i.p.; on days 1, 5, and 9; mice bearing B16 melanoma) shows the life-span is increased survives 77 to 86% longer than controls. Lewis lung carcinoma is highly sensitive to Sparfosic acid. Treatment on days 1, 5, and 9 following s.c. implantation of Lewis lung carcinoma is curative to 50% of the mice.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis
-
研究领域——
-
适应症——
化学信息
-
CAS Number51321-79-0
-
分子量255.12
-
分子式C6H10NO8P
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O 中的溶解度 : 125 mg/mL (489.97 mM; 超声助溶)
-
SMILES[C@H](NC(CP(=O)(O)O)=O)(CC(O)=O)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Wang J, et al. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol. 2015 Aug;47(2):782-90.?
产品手册
关联产品
-
ACBI1
ACBI1 是 BAF ATPase 亚基 SMARCA2 和 SMARCA4 的有效 PROTAC 降解剂,还可降解多溴相关 BAF (PBAF) 复合体成员 PBRM1,MV-4-中 SMARCA2、SMARCA4 和 PBRM1 的 DC50 分别为 6 nM、11 nM 和 32 nM分别为 11 个单元。
-
Atrosab
Atrosab 是一种人源化 IgG1 拮抗性抗 TNFR1 抗体。Atrosab 抑制 TNF 介导的细胞凋亡 (apoptosis) 以及 IL-6 和 IL-8 的产生。Atrosab 可用于炎症性疾病的研究。
-
Simmiparib
Simmiparib 是一种高效且具有口服活性的 PARP1 和 PARP2 抑制剂,IC50 分别为 1.75 nM 和 0.22 nM。Simmiparib 对 PARP1/2 的抑制作用强于其母体化合物 Olaparib (HY-10162)。在同源重组修复 (HR) 缺陷细胞中,Simmiparib 诱导 DNA 双链断裂 (DSB) 积累和 G2/M 阻滞,从而诱导细胞凋亡 (apoptosis)。Simmiparib 在细胞和裸鼠移植瘤模型中都表现出显著的抗癌活性。
021-51111890
购物车()
sales@molnova.cn

